08:35 AM EDT, 07/14/2025 (MT Newswires) -- Dare Bioscience ( DARE ) said Monday that interim results from its phase 3 clinical trial showed that its investigational monthly, hormone-free intravaginal contraceptive, Ovaprene, met the company's expectations. The company said about 9% of women treated in the trial had experienced a pregnancy during the interim analysis, consistent with what Dare Bioscience...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

NEW DELHI, July 14 (Reuters) - The Indian aviation regulator on Monday ordered Indian airlines to examine fuel switches on Boeing ( BA ) aircraft, including the 787 and 737 models, to check for any malfunctions in their locking mechanism. The Directorate General of Civil Aviation said it had issued the order after several Indian and international airlines began making...

08:34 AM EDT, 07/14/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Monday that Health Canada expanded the approval of Evkeeza as an adjunct to diet and other low-density lipoprotein cholesterol-lowering therapies to treat children with homozygous familial hypercholesterolemia aged six months or older. The drug first received Health Canada approval in September 2023 as an adjunct to diet...